{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T10:17:32Z","timestamp":1743070652349,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":12,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071639252"},{"type":"electronic","value":"9781071639269"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3926-9_6","type":"book-chapter","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T17:02:12Z","timestamp":1721667732000},"page":"81-89","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validated Methods for Effective Decontamination and Inactivation of Rift Valley Fever Virus"],"prefix":"10.1007","author":[{"given":"Marie-Pierre","family":"Confort","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Ratinier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9rick","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"issue":"6","key":"6_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1051\/vetres\/2010033","volume":"41","author":"M Pepin","year":"2010","unstructured":"Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J (2010) Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res 41(6):61. https:\/\/doi.org\/10.1051\/vetres\/2010033","journal-title":"Vet Res"},{"issue":"2","key":"6_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cll.2017.01.004","volume":"37","author":"A Hartman","year":"2017","unstructured":"Hartman A (2017) Rift Valley fever. Clin Lab Med 37(2):285\u2013301. https:\/\/doi.org\/10.1016\/j.cll.2017.01.004","journal-title":"Clin Lab Med"},{"issue":"3","key":"6_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4269\/ajtmh.2010.09-0669","volume":"82","author":"SS Kahlon","year":"2010","unstructured":"Kahlon SS, Peters CJ, Leduc J, Muchiri EM, Muiruri S, Njenga MK, Breiman RF, White AC Jr, King CH (2010) Severe Rift Valley fever may present with a characteristic clinical syndrome. Am J Trop Med Hygiene 82(3):371\u2013375. https:\/\/doi.org\/10.4269\/ajtmh.2010.09-0669","journal-title":"Am J Trop Med Hygiene"},{"issue":"1","key":"6_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009852","volume":"16","author":"KN Gerken","year":"2022","unstructured":"Gerken KN, LaBeaud AD, Mandi H, L\u2019Azou Jackson M, Breugelmans JG, King CH (2022) Paving the way for human vaccination against Rift Valley fever virus: a systematic literature review of RVFV epidemiology from 1999 to 2021. PLoS Negl Trop Dis 16(1):e0009852. https:\/\/doi.org\/10.1371\/journal.pntd.0009852","journal-title":"PLoS Negl Trop Dis"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","volume":"159","author":"MS Mehand","year":"2018","unstructured":"Mehand MS, Al-Shorbaji F, Millett P, Murgue B (2018) The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts. Antivir Res 159:63\u201367. https:\/\/doi.org\/10.1016\/j.antiviral.2018.09.009","journal-title":"Antivir Res"},{"key":"6_CR6","doi-asserted-by":"publisher","unstructured":"Petrova V, Kristiansen P, Norheim G, Yimer SA (2020) Rift valley fever: diagnostic challenges and investment needs for vaccine development. BMJ Global Health 5(8). https:\/\/doi.org\/10.1136\/bmjgh-2020-002694","DOI":"10.1136\/bmjgh-2020-002694"},{"issue":"Pt 10","key":"6_CR7","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","volume":"66","author":"H Caplen","year":"1985","unstructured":"Caplen H, Peters CJ, Bishop DH (1985) Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol 66(Pt 10):2271\u20132277. https:\/\/doi.org\/10.1099\/0022-1317-66-10-2271","journal-title":"J Gen Virol"},{"key":"6_CR8","doi-asserted-by":"crossref","unstructured":"Confort MP, Arnaud F, Ratinier M (2024) Guidelines for in vitro propagation and quantification of Rift Valley fever virus. Methods Mol Biol In press","DOI":"10.1007\/978-1-0716-3926-9_7"},{"issue":"Pt 12","key":"6_CR9","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1099\/vir.0.036749-0","volume":"92","author":"B Brennan","year":"2011","unstructured":"Brennan B, Li P, Elliott RM (2011) Generation and characterization of a recombinant Rift Valley fever virus expressing a V5 epitope-tagged RNA-dependent RNA polymerase. J Gen Virol 92(Pt 12):2906\u20132913. https:\/\/doi.org\/10.1099\/vir.0.036749-0","journal-title":"J Gen Virol"},{"key":"6_CR10","doi-asserted-by":"publisher","unstructured":"Confort MP, Duboeuf M, Thiesson A, Pons L, Marziali F, Desloire S, Ratinier M, Cimarelli A, Arnaud F (2023) IFITMs from naturally infected animal species exhibit distinct restriction capacities against Toscana and Rift Valley fever viruses. Viruses 15 (2). doi:https:\/\/doi.org\/10.3390\/v15020306","DOI":"10.3390\/v15020306"},{"issue":"4","key":"6_CR11","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1128\/JVI.02341-13","volume":"88","author":"AL Hartman","year":"2014","unstructured":"Hartman AL, Powell DS, Bethel LM, Caroline AL, Schmid RJ, Oury T, Reed DS (2014) Aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets. J Virol 88(4):2235\u20132245. https:\/\/doi.org\/10.1128\/JVI.02341-13","journal-title":"J Virol"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-1-59745-394-3_24","volume":"510","author":"BD Lindenbach","year":"2009","unstructured":"Lindenbach BD (2009) Measuring HCV infectivity produced in cell culture and in vivo. Methods Mol Biol 510:329\u2013336. https:\/\/doi.org\/10.1007\/978-1-59745-394-3_24","journal-title":"Methods Mol Biol"}],"container-title":["Methods in Molecular Biology","Rift Valley Fever Virus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3926-9_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T15:45:37Z","timestamp":1732463137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3926-9_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071639252","9781071639269"],"references-count":12,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3926-9_6","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"23 July 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}